Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

REVLIMID® Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patien

americanpharmaceuticalreviewFebruary 27, 2017

Tag: Revlimid® , multiple myeloma

PharmaSources Customer Service